A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

NCT02040792 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: TD-4208
DRUG: Placebo

Sponsor

Mylan Inc.

Collaborators

[object Object]